[1] 葛美玉,姜仲辉,王华.2002—2006年某院收治糖尿病现状分析[J].中国医院统计,2008,15(3):288. [2] HOFSTEN DE,LOGSTRUP BB,MOLLER JE,et al.Abnormal glucose metabolism in acute myocardial infarction: influence on left ventricular function and prognosis[J]. JACC Cardiovasc Imaging, 2009,2(5):592-599. [3] 陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:274-299,778-779. [4] 中华医学会糖尿病学分会.中国2型糖尿病防治指南2010[J].中国糖尿病杂志,2012,20(1): 后插1-后插36. [5] 李小鹰,丁文惠,华琦.老年人心房颤动诊治中国专家建议(2011)[J].中国实用内科杂志,2012,04:260-270. [6] The AFFIRM investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation[J]. N Engl J Med,2002,347:1825-1833. [7] 杨健威,李玉冰,李海珍.心房颤动患者的危险因素分析[J].实用老年医学,2010,23(3):229-230 [8] MARCUS GM, SMITH LM, ORDOVAS K, et al. Intra and extra cardiac markers of inflammation during aerial fibrillation[J]. Heart Rhythm, 2009,7(8):149-154. [9] LIN YJ, TSAO HM, CHANG SL, et al. Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation[J]. Am J Cardiol,2010,105(4):482-490. [10]SHAIKH AY, ESA N, MARTIN-DOYLE W, et al. Addition of B-Type Natriuretic Peptide to Existing Clinical Risk Scores Enhances Identification of Patients at Risk for Atrial Fibrillation Recurrence After Pulmonary Vein Isolation[J]. Crit Pathw Cardiol,2015,14(4):157-165. [11]SCHNABEL RB, LARSON MG, YAMAMOTO JF, et al. Relation of multiple inflammatory biomarkers to incident atrial fibrillation[J]. Am J Cardiol,2009,104(1):92-96. [12]SUZUKI S, SAGARA K, OTSUKA T, et al. Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence[J]. Circ J,2012,76(3):607-611. [13]SINGH JP, KULIK A, LEVIN R, et al. Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalizati[J]. Europace,2012,14(9):1287-1293.
